Evaluating Clinical Outcomes of Treatment Effectiveness for Children and Adults With ADHD
1 other identifier
observational
195
1 country
1
Brief Summary
To evaluate clinical effectiveness of medication treatment for ADHD. It is hypothesized that the effectiveness is lower than efficacy outcomes measured in clinical trials
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2008
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 23, 2006
CompletedFirst Posted
Study publicly available on registry
March 27, 2006
CompletedStudy Start
First participant enrolled
March 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedJanuary 23, 2013
January 1, 2013
1.8 years
March 23, 2006
January 21, 2013
Conditions
Keywords
Eligibility Criteria
Children and adolescents with a diagnosis of ADHD, aged 6 to 18 inclusive (at baseline), referred to the Provincial ADHD Program for clinical assessment.
You may qualify if:
- Meet DSM-IV criteria for ADHD
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of British Columbialead
- Eli Lilly and Companycollaborator
- Janssen-Ortho LLCcollaborator
- Purdue Universitycollaborator
- Shirecollaborator
Study Sites (1)
Children's and Women's Health Centre of BC
Vancouver, British Columbia, Canada
Related Publications (1)
Craig SG, Weiss MD, Hudec KL, Gibbins C. The Functional Impact of Sleep Disorders in Children With ADHD. J Atten Disord. 2020 Feb;24(4):499-508. doi: 10.1177/1087054716685840. Epub 2017 Jan 16.
PMID: 28093033DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Margaret Weiss, MD, PhD
The University of British Columbia
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 23, 2006
First Posted
March 27, 2006
Study Start
March 1, 2008
Primary Completion
January 1, 2010
Study Completion
December 1, 2012
Last Updated
January 23, 2013
Record last verified: 2013-01